Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Diffuse Tenosynovial Giant Cell Tumor

fluorodeoxyglucose f18 has been researched along with Diffuse Tenosynovial Giant Cell Tumor in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palmerini, E; Rimondi, E; Staals, EL1
Goldsmith, SJ; Lane, JM; Paul, JC; Unnanuntana, A1
Broski, SM; Murdoch, NM; Skinner, JA; Wenger, DE1
Blay, JY; Bompas, E; Cassier, PA; Dômont, J; Gelderblom, H; Italiano, A; Kroep, JR; Maki, RG; Seddon, B; Stacchiotti, S; Thomas, D; van der Graaf, WT; Wagner, AJ1
Ennis, F; Inneh, IA; Lee, MS; Simon, SL; Sullivan, S1
Coleman, RE; Kitapci, MT1
Nguyen, BD1

Other Studies

7 other study(ies) available for fluorodeoxyglucose f18 and Diffuse Tenosynovial Giant Cell Tumor

ArticleYear
A Mass With High Uptake of Fluorodeoxyglucose on Positron Emission Tomography.
    JAMA oncology, 2018, 10-01, Volume: 4, Issue:10

    Topics: Adolescent; Ankle Joint; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Synovitis, Pigmented Villonodular

2018
Extra-articular knee lesion with high fluorodeoxyglucose-uptake on positron emission tomography.
    Bulletin of the Hospital for Joint Disease (2013), 2013, Volume: 71, Issue:2

    Topics: Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Knee; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Synovitis, Pigmented Villonodular; Tendons

2013
Pigmented Villonodular Synovitis: Potential Pitfall on Oncologic 18F-FDG PET/CT.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:1

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Synovitis, Pigmented Villonodular; Tendons; Tomography, X-Ray Computed

2016
Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
    Cancer, 2012, Mar-15, Volume: 118, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Retrospective Studies; Synovitis, Pigmented Villonodular

2012
Tenosynovial giant cell tumor of the thigh: positron emission tomography findings.
    American journal of orthopedics (Belle Mead, N.J.), 2011, Volume: 40, Issue:6

    Topics: Adult; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Soft Tissue Neoplasms; Synovectomy; Synovial Membrane; Synovitis, Pigmented Villonodular; Thigh; Treatment Outcome

2011
Incidental detection of pigmented villonodular synovitis on FDG PET.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:8

    Topics: Back; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hip Joint; Humans; Incidental Findings; Melanoma; Middle Aged; Pelvic Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Synovitis, Pigmented Villonodular; Tomography, Emission-Computed

2003
PET, CT, and MR imaging of extra-articular pigmented villonodular synovitis.
    Clinical nuclear medicine, 2007, Volume: 32, Issue:6

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Synovitis, Pigmented Villonodular; Thigh; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging

2007